HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BBG2Na vaccine

a 38.7 kDa recombinant fusion protein produced in E coli, it comprises residues 130-230 of hRSV-A-G protein (G2Na) fused to BB, a carrier protein derived from the streptococcal protein G albumin binding domain
Also Known As:
BBG2Na
Networked: 5 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bonnefoy, J Y: 4 articles (12/2001 - 04/2000)
2. Plotnicky-Gilquin, H: 4 articles (12/2001 - 04/2000)
3. Nguyen, T N: 3 articles (12/2001 - 04/2000)
4. Power, U F: 3 articles (12/2001 - 04/2000)
5. Beck, A: 3 articles (06/2000 - 04/2000)
6. Champion, T: 2 articles (06/2000 - 06/2000)
7. Corvaïa, N: 2 articles (06/2000 - 06/2000)
8. Haeuw, J F: 2 articles (06/2000 - 04/2000)
9. Huss, T: 1 article (12/2001)
10. Michaud, V: 1 article (12/2001)

Related Diseases

1. Infections
2. Respiratory Syncytial Virus Infections
3. Respiratory Tract Diseases (Respiratory Tract Disease)

Related Drugs and Biologics

1. Respiratory Syncytial Virus Vaccines
2. Subunit Vaccines
3. GTP-Binding Proteins (G-Protein)
4. Chemokines
5. Recombinant Fusion Proteins
6. Phosphates (Orthophosphate)
7. Chemotactic Factors
8. Aluminum